Cited by 229Computational Drug Discovery MethodsMachine Learning in Materials ScienceSynthesis and Characterization of Heterocyclic Compounds

Shape-Based Generative Modeling for de Novo Drug Design

Skalic, Miha, Jiménez, José, Sabbadin, Davide, De Fabritiis, Gianni·2019·Journal of Chemical Information and Modeling

Abstract

In this work, we propose a machine learning approach to generate novel molecules starting from a seed compound, its three-dimensional (3D) shape, and its pharmacophoric features. The pipeline draws inspiration from generative models used in image analysis and represents a first example of the de novo design of lead-like molecules guided by shape-based features. A variational autoencoder is used to perturb the 3D representation of a compound, followed by a system of convolutional and recurrent neural networks that generate a sequence of SMILES tokens. The generative design of novel scaffolds and functional groups can cover unexplored regions of chemical space that still possess lead-like properties.

Integrity signals

Registry

Crossref · 10.1021/acs.jcim.8b00706

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These intricate and expansive architectures attain a SOTA level of validity and diversity in generated molecules but require extended time for completion.

    “Although these architectures attain a SOTA level of validity and diversity in generated molecules, the intricate nature of the process leads to an extension in the time required for completion.”
  • Several research studies propose intricate and expansive architectures to overcome the limitations of conditional VAEs.

    “To overcome these limitations, several research studies35,36 propose intricate and expansive architectures.”
  • Generative models have been used to compile focused and diversity-oriented chemical libraries, design inhibitors de novo, and perform hit-to-lead optimization, typically in a multiobjective mode.

    “Generative models have been used to compile both focused and diversity-oriented chemical libraries,149,150 to design inhibitors de novo,151 and to perform hit-to-lead optimization,152 typically in a multiobjective mode where e.g. selectivity, synthetic accessibility, and drug-like properties are improved simultaneously.153,154”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Skalic, M., Jiménez, J., Sabbadin, D., & De Fabritiis, G.
Affiliations
  • Computational Science Laboratory, Universitat Pompeu Fabra, Barcelona Biomedical Research Park (PRBB), C Dr Aiguader 88, 08003 Barcelona, Spain
  • Universitat Pompeu Fabra (ES)
Venue
Journal of Chemical Information and Modeling
Published
2019-02-14
Volume
59
Issue
3
Pages
1205-1214
ISSN
  • 1549-9596 (ISSN-L)
  • 1549-960X
OpenAlex
W2914635984
Cited by
229
References
51
Citations by year
2026: 13 · 2025: 21 · 2024: 34 · 2023: 42 · 2022: 30 · 2021: 51 · 2020: 27 · 2019: 10 · 2017: 1
FWCI
20.03
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Chemical Information and Modeling (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • H2020 Excellent Science (675451)
  • European Regional Development Fund
  • Ministerio de Econom?a y Competitividad (BIO2017-82628-P, MDM-2014-0370)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
Keywords
de novo drug design, variational autoencoder, pharmacophore features, SMILES generation, convolutional recurrent neural network, chemical space exploration, molecular scaffolds
MeSH terms
Machine Learning, Pharmaceutical Preparations, Hydrogen Bonding, Models, Molecular, Molecular Conformation, Drug Design, Molecular Structure, Quantitative Structure-Activity Relationship, Hydrophobic and Hydrophilic Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review